|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 08/25/08 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 07/25/07 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 30Cr 27Cr 25Cr 23Cr 43Cr 2.91TCr 44Cr 294.16Cr 115.38Cr 1.42TCr 114.44Cr 111.95Cr 4.94TCr | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 25Cr 23Cr 21Cr 40Cr 2.68TCr 40Cr 271.01Cr 106.3Cr 1.31TCr 105.44Cr 103.15Cr 4.55TCr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.42% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 4.13 |  | 6.28 |
| 3 years | 1.94 | | 8.83 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 07/10/2025 |
| Director of Finance/CFO | 50 | 07/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 07/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 07/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 07/10/2025 |
| Director/Board Member | 50 | 07/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/25/07 | Tender | Chairman | 77,174 | 0.1542% | ||
| 07/25/07 | Issuer sale | Director | 49,750 | 0.0994% | ||
| 07/25/07 | Issuer sale | Director | 84,422 | 0.1687% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +29.45% | -36.36% | 30Cr | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,06000Cr | |
| -0.82% | -2.30% | +63.79% | +62.00% | 62TCr | |
| -0.73% | -4.98% | +28.91% | +82.99% | 44TCr | |
| +0.33% | -1.17% | +31.07% | +27.09% | 33TCr | |
| -0.02% | -2.85% | +29.15% | +45.24% | 28TCr | |
| -3.89% | -11.22% | +22.81% | +27.30% | 27TCr | |
| +0.66% | -1.42% | -26.59% | -37.71% | 22TCr | |
| -0.06% | -2.88% | +23.07% | +62.33% | 20TCr | |
| -3.72% | -1.10% | +18.41% | +70.56% | 16TCr | |
| Average | -1.06% | -2.92% | +27.00% | +47.39% | 35.74TCr | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.90% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
